Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis
    Wang, Anrong
    Li, Junfeng
    Li, Changfeng
    Zhang, Hui
    Fan, Yingfang
    Ma, Kuansheng
    Wang, Qiang
    HELIYON, 2024, 10 (03)
  • [42] Prognostic Impact of Monocyte to Lymphocyte Ratio in Clinical Outcome of Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Nouri-Vaskeh, Masoud
    Mirza-Aghazadeh-Attari, Mohammad
    Pashazadeh, Fariba
    Azami-Aghdash, Saber
    Alizadeh, Hadi
    Pouya, Parnia
    Halimi, Monireh
    Jadideslam, Golamreza
    Zarei, Mohammad
    GALEN MEDICAL JOURNAL, 2020, 9
  • [43] Metabolic syndrome and survival of patients with hepatocellular carcinoma: A meta-analysis
    Fu, Jia
    Jiang, Jinqiong
    Liu, Kanghan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
    Bang, Chang Seok
    Song, Il Han
    BMC GASTROENTEROLOGY, 2017, 17
  • [45] Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
    Chang Seok Bang
    Il Han Song
    BMC Gastroenterology, 17
  • [46] Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis
    Zhang, Zhaohui
    Zhang, Yi
    Wang, Wei
    Hua, Yunpeng
    Liu, Linyun
    Shen, Shunli
    Peng, Baogang
    JOURNAL OF SURGICAL RESEARCH, 2017, 210 : 99 - 107
  • [47] Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients
    Beumer, Berend R.
    Buettner, Stefan
    Galjart, Boris
    van Vugt, Jeroen L. A.
    de Man, Robert A.
    IJzermans, Jan N. M.
    Koerkamp, Bas Groot
    EJSO, 2022, 48 (03): : 492 - 499
  • [48] The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma A Systematic Review and Meta-Analysis
    Pang, Qing
    Qu, Kai
    Zhang, Jing-Yao
    Song, Si-Dong
    Liu, Su-Shun
    Tai, Ming-Hui
    Liu, Hao-Chen
    Liu, Chang
    MEDICINE, 2015, 94 (37)
  • [49] Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review
    Wang, Guiliang
    Liu, Yan
    Zhou, Shu-feng
    Qiu, Ping
    Xu, Linfang
    Wen, Ping
    Wen, Jianbo
    Xiao, Xianzhong
    HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 501 - 510
  • [50] Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis A Systematic Review and Meta-Analysis
    Ramai, Daryl
    Singh, Jameel
    Chandan, Saurabh
    Tartaglia, Nicola
    Ambrosi, Antonio
    Khan, Shahab R.
    Sacco, Rodolfo
    Facciorusso, Antonio
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 198 - 203